887 Spam-Free Article(s) Found
Sort:
Date
Filter:
All
Article Searches
New Jersey brothers face kidnapping, sexual assault charges after picking up four minors: police https://www.nydailynews.com/news/crime/ny-new-jersey-brothers-20200504-3fxpxyvmezablj7w6qwcbauffe-story.html#ed=rss_www.nydailynews.com/arcio/rss/category/news/ May 04, 2020 - Two brothers in New Jersey who approached four juveniles out walking and offered them a ride now face kidnapping and sexual assault charges, authorities said Sunday.
New Jersey brothers face kidnapping, sexual assault charges after picking up four minors: police https://www.nydailynews.com/news/crime/ny-new-jersey-brothers-20200504-3fxpxyvmezablj7w6qwcbauffe-story.html#ed=rss_www.nydailynews.com/arcio/rss/category/news/crime/ May 04, 2020 - Two brothers in New Jersey who approached four juveniles out walking and offered them a ride now face kidnapping and sexual assault charges, authorities said Sunday.
Coronavirus Live Updates: Trump Accuses China of a Cover-Up https://www.nytimes.com/2020/05/04/us/coronavirus-updates.html May 04, 2020 - Tensions between Washington and Beijing escalated as President Trump said the U.S. death toll could reach 100,000. The Supreme Court is hearing a case remotely for the first time.
CNI: Wolfe Research ups to Outperform https://www.briefing.com/in-depth-analysis/Content/Article?ArticleId=UD20200504093258 May 04, 2020 - Wolfe Research issues rating change for CNI
Kala Pharma refiles dry eye application in U.S.; shares up 2% premarket https://seekingalpha.com/news/3568243-kala-pharma-refiles-dry-eye-application-in-u-s-shares-up-2-premarket?source=feed_sector_healthcare May 04, 2020 - Kala Pharmaceuticals (NASDAQ:KALA) has resubmitted its U.S. marketing application for Eysuvis (loteprednol etabonate ophthalmic suspension) 0.25% for the short-term treatment of symptoms of dry eye di
Lilly teams up with Junshi Bio to develop COVID-19 treatments https://seekingalpha.com/news/3568205-lilly-teams-up-junshi-bio-to-develop-covidminus-19-treatments?source=feed_sector_healthcare May 04, 2020 - Eli Lilly (NYSE:LLY) inks an agreement with Shanghai-based Junshi Biosciences to co-develop therapeutics antibodies for the potential treatment and prevention of COVID-19.Junshi's lead program appears
AGNC: Maxim Group ups to Buy https://www.briefing.com/in-depth-analysis/Content/Article?ArticleId=UD20200504075149 May 04, 2020 - Maxim Group issues rating change for AGNC
Anixa Bio up 62% premarket on discovery of first COVID-19 candidate https://seekingalpha.com/news/3568129-anixa-bio-up-62-premarket-on-discovery-of-first-covidminus-19-candidate?source=feed_sector_healthcare May 04, 2020 - Anixa Biosciences (NASDAQ:ANIX), together with partner OntoChem GmbH, has identified its first therapeutic candidate against COVID-19 and has advanced the compound into biological testing. The compou
Mallinckrodt up 9% premarket on positive INOmax data https://seekingalpha.com/news/3568125-mallinckrodt-up-9-premarket-on-positive-inomax-data?source=feed_sector_healthcare May 04, 2020 - Mallinckrodt (NYSE:MNK) announces positive results from its observational registry comparing the safety and effectiveness of INOmax (nitric oxide) gas for inhalation in term and near-term neonates wit
Applied DNA Sciences up 24% on encouraging COVID-19 vaccine data https://seekingalpha.com/news/3568107-applied-dna-sciences-up-24-on-encouraging-covidminus-19-vaccine-data?source=feed_sector_healthcare May 04, 2020 - Nano cap Applied DNA Sciences (NASDAQ:APDN) and COVID-19 vaccine development partner Takis Biotech announce that the first injections of their DNA vaccine candidates against the SARS-CoV-2 spike prote

Pages: 123456...89

Page 1>